The homing of human cord blood stem cells to sites of inflammation

References

• Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993; 71:2585 - 97; http://dx.doi.org/10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S; PMID: 8453582
   PubMed Web of Science ®Google Scholar
• Surawicz TS, Davis F, Freels S, Laws ER Jr., Menck HR. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 1998; 40:151 - 60; http://dx.doi.org/10.1023/A:1006091608586; PMID: 9892097
   PubMed Web of Science ®Google Scholar
• Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 2008; 15:739 - 52; http://dx.doi.org/10.1038/gt.2008.41; PMID: 18369324
   PubMed Web of Science ®Google Scholar
• Louis DN, Posner J, Jacobs T, Kaplan R, Report of the Brain Tumor Progress Review Group. National Institute of Neurological Disorders and Stroke 2000; 1 - 96
   Google Scholar
• Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756 - 60; http://dx.doi.org/10.1038/nature05236; PMID: 17051156
   PubMed Web of Science ®Google Scholar
• Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5:67; http://dx.doi.org/10.1186/1476-4598-5-67; PMID: 17140455
   PubMed Web of Science ®Google Scholar
• Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65:3307 - 18; PMID: 15833864
   PubMed Web of Science ®Google Scholar
• Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002; 62:7170 - 4; PMID: 12499252
   PubMed Web of Science ®Google Scholar
• Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002; 62:5657 - 63; PMID: 12384520
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24:1294 - 301; http://dx.doi.org/10.1634/stemcells.2005-0342; PMID: 16410387
   PubMed Web of Science ®Google Scholar
• Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q, et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 2008; 32:8 - 15; http://dx.doi.org/10.1016/j.cellbi.2007.08.002; PMID: 17904875
   PubMed Web of Science ®Google Scholar
• Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005; 33:1402 - 16; http://dx.doi.org/10.1016/j.exphem.2005.07.003; PMID: 16263424
   PubMed Web of Science ®Google Scholar
• Gondi CS, Veeravalli KK, Gorantla B, Dinh DH, Fassett D, Klopfenstein JD, et al. Human umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo.. Neuro Oncol 2010; 12:453 - 65; PMID: 20406896
   PubMed Web of Science ®Google Scholar
• Kim DS, Kim JH, Lee JK, Choi SJ, Kim JS, Jeun SS, et al. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev 2009; 18:511 - 9; http://dx.doi.org/10.1089/scd.2008.0050; PMID: 18624673
   PubMed Web of Science ®Google Scholar
• Park SA, Ryu CH, Kim SM, Lim JY, Park SI, Jeong CH, et al. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Int J Oncol 2011; 38:97 - 103; PMID: 21109930
   PubMed Web of Science ®Google Scholar
• Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007; 13:5020 - 7; http://dx.doi.org/10.1158/1078-0432.CCR-07-0731; PMID: 17785552
   PubMed Web of Science ®Google Scholar
• Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283:845 - 8; http://dx.doi.org/10.1126/science.283.5403.845; PMID: 9933168
   PubMed Web of Science ®Google Scholar
• Dasari VR, Velpula KK, Kaur K, Fassett D, Klopfenstein JD, Dinh DH, et al. Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS One 2010; 5:e11813; http://dx.doi.org/10.1371/journal.pone.0011813; PMID: 20676365
   PubMedGoogle Scholar
• Dasari VR, Kaur K, Velpula KK, Dinh DH, Tsung AJ, Mohanam S, et al. Downregulation of Focal Adhesion Kinase (FAK) by cord blood stem cells inhibits angiogenesis in glioblastoma. Aging 2010; 2:791 - 803; PMID: 20228937
   PubMedGoogle Scholar
• Dasari VR, Kaur K, Velpula KK, Gujrati M, Fassett D, Klopfenstein JD, et al. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS One 2010; 5:e10350; http://dx.doi.org/10.1371/journal.pone.0010350; PMID: 20436671
   PubMedGoogle Scholar
• Gondi CS, Gogineni VR, Chetty C, Dasari VR, Gorantla B, Gujrati M, et al. Induction of apoptosis in glioma cells requires cell-to-cell contact with human umbilical cord blood stem cells. Int J Oncol 2010; 36:1165 - 73; PMID: 20372790
   PubMed Web of Science ®Google Scholar
• Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101:2999 - 3001; http://dx.doi.org/10.1182/blood-2002-06-1830; PMID: 12480709
   PubMed Web of Science ®Google Scholar
• Oh W, Kim DS, Yang YS, Lee JK. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol 2008; 251:116 - 23; http://dx.doi.org/10.1016/j.cellimm.2008.04.003; PMID: 18495100
   PubMed Web of Science ®Google Scholar
• Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, et al. Immunogenicity of umbilical cord tissue derived cells. Blood 2008; 111:430 - 8; http://dx.doi.org/10.1182/blood-2007-03-078774; PMID: 17909081
   PubMed Web of Science ®Google Scholar
• Ji F, Wang Y, Sun H, Du J, Zhao H, Wang D, et al. Human umbilical cord blood-derived non-hematopoietic stem cells suppress lymphocyte proliferation and CD4, CD8 expression. J Neuroimmunol 2008; 197:99 - 109; http://dx.doi.org/10.1016/j.jneuroim.2008.04.013; PMID: 18534691
   PubMed Web of Science ®Google Scholar
• Wang M, Yang Y, Yang D, Luo F, Liang W, Guo S, et al. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009; 126:220 - 32; http://dx.doi.org/10.1111/j.1365-2567.2008.02891.x; PMID: 18624725
   PubMed Web of Science ®Google Scholar
• Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 2009; 259:150 - 6; http://dx.doi.org/10.1016/j.cellimm.2009.06.010; PMID: 19608159
   PubMed Web of Science ®Google Scholar
• Velpula KK, Dasari VR, Tsung AJ, Dinh DH, Rao JS. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1. Oncotarget 2011; 2:1028 - 42; PMID: 22184289
   PubMed Web of Science ®Google Scholar
• Velpula KK, Dasari VR, Tsung AJ, Gondi CS, Klopfenstein JD, Mohanam S, et al. Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1. PLoS One 2011; 6:e18017; http://dx.doi.org/10.1371/journal.pone.0018017; PMID: 21455311
   PubMedGoogle Scholar
• Jenhani F, Durand V, Ben Azouna N, Thallet S, Ben Othmen T, Bejaoui M, et al. Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells. Transplant Proc 2011; 43:639 - 43; http://dx.doi.org/10.1016/j.transproceed.2011.01.021; PMID: 21440783
   PubMed Web of Science ®Google Scholar
• Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 2005; 32:270 - 9; http://dx.doi.org/10.1016/j.cyto.2005.11.003; PMID: 16377203
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007; 25:1737 - 45; http://dx.doi.org/10.1634/stemcells.2007-0054; PMID: 17395768
   PubMed Web of Science ®Google Scholar
• Yan XL, Liu B, Mao N. [Study on migration property of mesenchymal stem cells-review]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009; 17:1101 - 5; PMID: 19698270
   PubMedGoogle Scholar
• Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000; 95:3289 - 96; PMID: 10828007
   PubMed Web of Science ®Google Scholar
• Bonavia R, Inda MM, Cavenee WK, Furnari FB. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res 2011; 71:4055 - 60; http://dx.doi.org/10.1158/0008-5472.CAN-11-0153; PMID: 21628493
   PubMed Web of Science ®Google Scholar
• Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008; 13:69 - 80; http://dx.doi.org/10.1016/j.ccr.2007.12.005; PMID: 18167341
   PubMed Web of Science ®Google Scholar
• Vik-Mo EO, Sandberg C, Olstorn H, Varghese M, Brandal P, Ramm-Pettersen J, et al. Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions. Neuro Oncol 2010; 12:1220 - 30; PMID: 20843775
   PubMed Web of Science ®Google Scholar
• Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105:369 - 77; http://dx.doi.org/10.1016/S0092-8674(01)00328-2; PMID: 11348593
   PubMed Web of Science ®Google Scholar
• Tabatabai G, Bähr O, Möhle R, Eyüpoglu IY, Boehmler AM, Wischhusen J, et al. Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain 2005; 128:2200 - 11; http://dx.doi.org/10.1093/brain/awh563; PMID: 15947066
   PubMed Web of Science ®Google Scholar
• Schmidt NO, Przylecki W, Yang W, Ziu M, Teng Y, Kim SU, et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005; 7:623 - 9; http://dx.doi.org/10.1593/neo.04781; PMID: 16036113
   PubMed Web of Science ®Google Scholar
• Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008; 68:9614 - 23; http://dx.doi.org/10.1158/0008-5472.CAN-08-0451; PMID: 19047138
   PubMed Web of Science ®Google Scholar
• Ryu CH, Park SH, Park SA, Kim SM, Lim JY, Jeong CH, et al. Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells. Hum Gene Ther 2011; 22:733 - 43; http://dx.doi.org/10.1089/hum.2010.187; PMID: 21261460
   PubMed Web of Science ®Google Scholar
• Park JH, Ryu JM, Han HJ. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways. J Cell Physiol 2011; 226:267 - 75; http://dx.doi.org/10.1002/jcp.22338; PMID: 20658539
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32:1005 - 11; http://dx.doi.org/10.1161/01.STR.32.4.1005; PMID: 11283404
   PubMed Web of Science ®Google Scholar
• Wang L, Li Y, Chen J, Gautam SC, Zhang Z, Lu M, et al. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol 2002; 30:831 - 6; http://dx.doi.org/10.1016/S0301-472X(02)00829-9; PMID: 12135683
   PubMed Web of Science ®Google Scholar
• Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y, et al. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 2002; 7:113 - 7; http://dx.doi.org/10.1080/10245330290028588; PMID: 12186702
   PubMedGoogle Scholar
• Ji JF, He BP, Dheen ST, Tay SS. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004; 22:415 - 27; http://dx.doi.org/10.1634/stemcells.22-3-415; PMID: 15153618
   PubMed Web of Science ®Google Scholar
• Bieback K, Kern S, Klüter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004; 22:625 - 34; http://dx.doi.org/10.1634/stemcells.22-4-625; PMID: 15277708
   PubMed Web of Science ®Google Scholar
• von Drygalski A, Adamson JW. Placental/umbilical cord blood (PCB) stem cells for transplantation: early clinical outcomes and the status of ex vivo expansion strategies. Keio J Med 2000; 49:141 - 51; http://dx.doi.org/10.2302/kjm.49.141; PMID: 11192982
   PubMedGoogle Scholar
• Weiss ML, Mitchell KE, Hix JE, Medicetty S, El-Zarkouny SZ, Grieger D, et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol 2003; 182:288 - 99; http://dx.doi.org/10.1016/S0014-4886(03)00128-6; PMID: 12895440
   PubMed Web of Science ®Google Scholar
• Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol 2007; 28:219 - 26; http://dx.doi.org/10.1016/j.it.2007.03.001; PMID: 17400510
   PubMed Web of Science ®Google Scholar
• Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9:391 - 403; http://dx.doi.org/10.1016/j.ccr.2006.03.030; PMID: 16697959
   PubMed Web of Science ®Google Scholar
• Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, et al. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004; 23:4681 - 9; http://dx.doi.org/10.1038/sj.onc.1207616; PMID: 15122332
   PubMed Web of Science ®Google Scholar